OTC review agenda
This article was originally published in The Rose Sheet
Executive SummaryProposed rule on convenience size OTC products now targeted for release in September, according to FDA's 1unified agenda published in the Federal Register May 27. Most recent timeline predicted completion in March. NPR on UVA/UVB sunscreen products is slated for December, while earlier estimates had projected an April timeline. Antiperspirant products final action is anticipated in August, while final action on skin protectant products is slated for July and NPR on astringents is planned for September. ANPR for plaque/gingivitis products was released May 29 (see story, p. 3)...
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Crude heparin supplier Yibin Lihao headlines list of facilities in 12 countries added to the US FDA’s drug GMP import alert.
Tschudin talked to Scrip about taking over as Novartis Pharmaceuticals president, why inclisiran is different from marketed PCSK9 inhibitors and prioritizing investment behind multiple new launches.